Quarterly report pursuant to Section 13 or 15(d)

Stock Warrants (Details) - Schedule of summary of the warrant activity

v3.21.2
Stock Warrants (Details) - Schedule of summary of the warrant activity
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2021
USD ($)
$ / shares
shares
Schedule of summary of the warrant activity [Abstract]  
Number of Shares, beginning | shares
Weighted Average Exercise Price, beginning | $ / shares
Weighted Average Remaining Contractual Term in Years, beginning
Aggregate Intrinsic Value, beginning | $ [1]
Number of Shares, Granted | shares 7,083,500
Weighted Average Exercise Price, Granted | $ / shares $ 0.05
Weighted Average Remaining Contractual Term in Years, Granted 4 years 9 months 18 days
Aggregate Intrinsic Value, Granted | $ [1]
Number of Shares, ending | shares 7,083,500
Weighted Average Exercise Price, ending | $ / shares $ 0.05
Weighted Average Remaining Contractual Term in Years, ending 4 years 9 months 18 days
Aggregate Intrinsic Value, ending | $ $ 390 [1]
Number of Shares, Exercisable | shares 7,083,500
Weighted Average Exercise Price, Exercisable | $ / shares $ 0.05
Weighted Average Remaining Contractual Term in Years, Exercisable 4 years 9 months 18 days
Aggregate Intrinsic Value, Exercisable | $ $ 390 [1]
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.105 for our common stock on June 30, 2021.